Disagreement between EU ministers over extending the pharmaceutical monopoly in the biotechnology law debate

EU health ministers are divided over a proposal to give some innovative medicines an additional year of market protection, with the Health Commissioner stressing that the incentive is needed to keep biotech investments in Europe, while the incoming Irish presidency pledges to move quickly.